| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |